BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.86% |
| 2 | Consumer Discretionary | 6.16% |
| 3 | Healthcare | 5.91% |
| 4 | Communication Services | 5.19% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Eagle Bancorp Montana
EBMT
$189M
| $4.1K | ﹤0.01% |
+236
| New | +$4.02K |
|
|
GPX
3927
DELISTED
GP Strategies Corp.
GPX
| $4.1K | ﹤0.01% |
478
-3,505
| -88% | -$25.2K |
|
3928
Nexa Resources
NEXA
$1.92B
| $4.1K | ﹤0.01% |
617
-3,622
| -85% | -$16.1K |
|
3929
First Community Corp
FCCO
$324M
| $4.06K | ﹤0.01% |
268
+231
| +624% | +$3.46K |
|
|
PZN
3930
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $4.05K | ﹤0.01% |
745
-4,825
| -87% | -$22.5K |
|
3931
Arq
ARQ
$100M
| $4.05K | ﹤0.01% |
835
-4,265
| -84% | -$24.6K |
|
3932
CB Financial Services
CBFV
$190M
| $4.04K | ﹤0.01% |
185
+159
| +612% | +$3.55K |
|
3933
Research Frontiers
REFR
$15.2M
| $4.04K | ﹤0.01% |
+994
| New | +$3.69K |
|
|
VANIW
3934
DELISTED
Vivani Medical, Inc. Warrants expiring 03/14/2024
VANIW
| $4.03K | ﹤0.01% |
34,146
-21,636
| -39% | -$2.21K |
|
3935
Electromed
ELMD
$355M
| $4.02K | ﹤0.01% |
+261
| New | +$3.61K |
|
3936
iBio
IBIO
$67.1M
| $4K | ﹤0.01% |
+4
| New | +$2.62K |
|
|
ICBK
3937
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $3.98K | ﹤0.01% |
190
+161
| +555% | +$3.28K |
|
|
INDT
3938
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $3.95K | ﹤0.01% |
73
-242
| -77% | -$10K |
|
3939
Duluth Holdings
DLTH
$151M
| $3.94K | ﹤0.01% |
534
-2,786
| -84% | -$14.2K |
|
3940
Northeast Bank
NBN
$1.16B
| $3.93K | ﹤0.01% |
224
-2,351
| -91% | -$35.7K |
|
|
SAL
3941
DELISTED
Salisbury Bancorp, Inc.
SAL
| $3.89K | ﹤0.01% |
+190
| New | +$3.45K |
|
|
EVBN
3942
DELISTED
Evans Bancorp Inc
EVBN
| $3.88K | ﹤0.01% |
167
-1,313
| -89% | -$32.2K |
|
3943
Genie Energy
GNE
$383M
| $3.86K | ﹤0.01% |
524
-3,853
| -88% | -$30.2K |
|
|
VWTR
3944
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $3.85K | ﹤0.01% |
457
-5,140
| -92% | -$41.1K |
|
3945
Galectin Therapeutics
GALT
$336M
| $3.85K | ﹤0.01% |
1,258
-11,202
| -90% | -$28.2K |
|
3946
Plumas Bancorp
PLBC
$442M
| $3.85K | ﹤0.01% |
+174
| New | +$3.37K |
|
|
APTX
3947
DELISTED
Aptinyx Inc. Common Stock
APTX
| $3.84K | ﹤0.01% |
920
+913
| +13,043% | +$3.09K |
|
3948
First Bank
FRBA
$466M
| $3.83K | ﹤0.01% |
588
-4,590
| -89% | -$32.5K |
|
3949
Gyre Therapeutics
GYRE
$695M
| $3.83K | ﹤0.01% |
87
+79
| +988% | +$3.71K |
|
3950
Bankwell Financial Group
BWFG
$546M
| $3.82K | ﹤0.01% |
240
-1,832
| -88% | -$27.2K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.